{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:09:55Z","timestamp":1789052995645,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371512"],"award-info":[{"award-number":["82371512"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571719"],"award-info":[{"award-number":["82571719"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Tianjin Key Medical Discipline Construction Project","award":["TJYXZDXK-3-015B"],"award-info":[{"award-number":["TJYXZDXK-3-015B"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00406-026-02358-z","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T07:57:05Z","timestamp":1788076625000},"page":"3935-3948","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Untargeted plasma metabolomics identifies metabolite signatures associated with suicidality status in chronic schizophrenia"],"prefix":"10.1007","volume":"276","author":[{"given":"Lijun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7157-7945","authenticated-orcid":false,"given":"Shen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,30]]},"reference":[{"key":"2358_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","volume":"77","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Reis Marques T, Howes OD (2020) Schizophrenia\u2014an overview. JAMA Psychiat 77:201\u2013210","journal-title":"JAMA Psychiat"},{"key":"2358_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/wps.20994","volume":"21","author":"CU Correll","year":"2022","unstructured":"Correll CU, Solmi M, Croatto G, Schneider LK, Rohani-Montez SC, Fairley L, Smith N, Bitter I, Gorwood P, Taipale H, Tiihonen J (2022) Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry 21:248\u2013271","journal-title":"World Psychiatry"},{"key":"2358_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55070361","author":"L Sher","year":"2019","unstructured":"Sher L, Kahn RS (2019) Suicide in schizophrenia: an educational overview. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina55070361","journal-title":"Medicina (Kaunas)"},{"key":"2358_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/archpsyc.62.3.247","volume":"62","author":"BA Palmer","year":"2005","unstructured":"Palmer BA, Pankratz VS, Bostwick JM (2005) The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry 62:247\u2013253","journal-title":"Arch Gen Psychiatry"},{"key":"2358_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1097098","volume":"11","author":"Y Liang","year":"2023","unstructured":"Liang Y, Wu M, Zou Y, Wan X, Liu Y, Liu X (2023) Prevalence of suicide ideation, self-harm, and suicide among Chinese patients with schizophrenia: a systematic review and meta-analysis. Front Public Health 11:1097098","journal-title":"Front Public Health"},{"key":"2358_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-025-07306-0","volume":"25","author":"C Lu","year":"2025","unstructured":"Lu C, Qi D, Ping Y, Zhang C, Wang S, Liu N, Wang X, Li S, Li J (2025) Suicide risk, psychopathology and cognitive impairments in schizophrenia with insomnia: a large-scale cross-sectional study. BMC Psychiatry 25:920","journal-title":"BMC Psychiatry"},{"key":"2358_CR7","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21:1696\u20131709","journal-title":"Mol Psychiatry"},{"key":"2358_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.euroneuro.2023.05.009","volume":"75","author":"SP Neupane","year":"2023","unstructured":"Neupane SP, Daray FM, Ballard ED, Galfalvy H, Itzhaky L, Segev A, Shelef A, Tene O, Rizk MM, Mann JJ, Zalsman G (2023) Immune-related biomarkers and suicidal behaviors: a meta-analysis. Eur Neuropsychopharmacol 75:15\u201330","journal-title":"Eur Neuropsychopharmacol"},{"key":"2358_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-021-00161-4","volume":"7","author":"EF Osimo","year":"2021","unstructured":"Osimo EF, Baxter L, Stochl J, Perry BI, Metcalf SA, Kunutsor SK, Laukkanen JA, Wium-Andersen MK, Jones PB, Khandaker GM (2021) Longitudinal association between CRP levels and risk of psychosis: a meta-analysis of population-based cohort studies. npj Schizophr 7:31","journal-title":"npj Schizophr"},{"key":"2358_CR10","first-page":"343","volume":"45","author":"ME Inam","year":"2023","unstructured":"Inam ME, Fernandes BS, Salagre E, Grande I, Vieta E, Quevedo J, Zhao Z (2023) The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies. Braz J Psychiatry 45:343\u2013355","journal-title":"Braz J Psychiatry"},{"key":"2358_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2022.110668","volume":"121","author":"SR Patlola","year":"2023","unstructured":"Patlola SR, Donohoe G, McKernan DP (2023) The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 121:110668","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2358_CR12","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1038\/tp.2012.76","volume":"2","author":"Y He","year":"2012","unstructured":"He Y, Yu Z, Giegling I, Xie L, Hartmann A, Prehn C, Adamski J, Kahn R, Li Y, Illig T (2012) Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry 2:e149\u2013e149","journal-title":"Transl Psychiatry"},{"key":"2358_CR13","doi-asserted-by":"crossref","unstructured":"Okamoto N, Ikenouchi A, Watanabe K, Igata R, Fujii R, Yoshimura R (2021) A metabolomics study of serum in hospitalized patients with chronic schizophrenia. Front Psychiat 12","DOI":"10.3389\/fpsyt.2021.763547"},{"key":"2358_CR14","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/schbul\/sbaa052","volume":"46","author":"K Esaki","year":"2020","unstructured":"Esaki K, Balan S, Iwayama Y, Shimamoto-Mitsuyama C, Hirabayashi Y, Dean B, Yoshikawa T (2020) Evidence for altered metabolism of sphingosine-1-phosphate in the corpus callosum of patients with schizophrenia. Schizophr Bull 46:1172\u20131181","journal-title":"Schizophr Bull"},{"key":"2358_CR15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/schbul\/sbs058","volume":"39","author":"S Smesny","year":"2013","unstructured":"Smesny S, Schmelzer CE, Hinder A, K\u00f6hler A, Schneider C, Rudzok M, Schmidt U, Milleit B, Milleit C, Nenadic I (2013) Skin ceramide alterations in first-episode schizophrenia indicate abnormal sphingolipid metabolism. Schizophr Bull 39:933\u2013941","journal-title":"Schizophr Bull"},{"key":"2358_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jpsychires.2018.04.002","volume":"102","author":"D Wang","year":"2018","unstructured":"Wang D, Sun X, Yan J, Ren B, Cao B, Lu Q, Liu Y, Zeng J, Huang N, Xie Q (2018) Alterations of eicosanoids and related mediators in patients with schizophrenia. J Psychiatr Res 102:168\u2013178","journal-title":"J Psychiatr Res"},{"key":"2358_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv096","author":"S Sethi","year":"2015","unstructured":"Sethi S, Brietzke E (2015) Omics-based biomarkers: application of metabolomics in neuropsychiatric disorders. Int J Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyv096","journal-title":"Int J Neuropsychopharmacol"},{"key":"2358_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115682","volume":"332","author":"CA Pereira","year":"2024","unstructured":"Pereira CA, Reis-de-Oliveira G, Pierone BC, Martins-de-Souza D, Kaster MP (2024) Depicting the molecular features of suicidal behavior: a review from an \u201comics\u201d perspective. Psychiatry Res 332:115682","journal-title":"Psychiatry Res"},{"key":"2358_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116742","author":"KJ Panganiban","year":"2025","unstructured":"Panganiban KJ, Smith EC, Stogios N, Agarwal SM, Ward K, Hahn MK (2025) The cognitive metabolomic signatures in schizophrenia spectrum disorders: a systematic review. Psychiatry Res. https:\/\/doi.org\/10.1016\/j.psychres.2025.116742","journal-title":"Psychiatry Res"},{"key":"2358_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-025-07059-w","volume":"25","author":"Q Zhu","year":"2025","unstructured":"Zhu Q, Wang J, Wang Y, Zhang X-Y (2025) The association of age of onset on suicide attempts in patients with chronic schizophrenia: a cross-sectional study. BMC Psychiatry 25:600","journal-title":"BMC Psychiatry"},{"key":"2358_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"2358_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","volume":"20","author":"C Randolph","year":"1998","unstructured":"Randolph C, Tierney MC, Mohr E, Chase TN (1998) The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 20:310\u2013319","journal-title":"J Clin Exp Neuropsychol"},{"key":"2358_CR23","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1176\/ajp.156.12.1944","volume":"156","author":"JM Gold","year":"1999","unstructured":"Gold JM, Queern C, Iannone VN, Buchanan RW (1999) Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia part I: sensitivity, reliability, and validity. Am J Psychiatry 156:1944\u20131950","journal-title":"Am J Psychiatry"},{"key":"2358_CR24","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1176\/ajp.156.12.1951","volume":"156","author":"MP Hobart","year":"1999","unstructured":"Hobart MP, Goldberg R, Bartko JJ, Gold JM (1999) Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, part II: convergent\/discriminant validity and diagnostic group comparisons. Am J Psychiatry 156:1951\u20131957","journal-title":"Am J Psychiatry"},{"key":"2358_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.schres.2003.10.009","volume":"70","author":"CM Wilk","year":"2004","unstructured":"Wilk CM, Gold JM, Humber K, Dickerson F, Fenton WS, Buchanan RW (2004) Brief cognitive assessment in schizophrenia: normative data for the repeatable battery for the assessment of neuropsychological status. Schizophr Res 70:175\u2013186","journal-title":"Schizophr Res"},{"key":"2358_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2358_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","author":"M Hamilton","year":"1959","unstructured":"Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol. https:\/\/doi.org\/10.1111\/j.2044-8341.1959.tb00467.x","journal-title":"Br J Med Psychol"},{"key":"2358_CR28","unstructured":"Han Y, Wang L, Sun W, Dong Y, Li Y, Liu N, Wang X, Li J (2025) Cognitive impairments and plasma metabolic characteristics in deficit schizophrenia: a two-year follow-up longitudinal study."},{"key":"2358_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2115753118","volume":"119","author":"B Du","year":"2022","unstructured":"Du B, Ding D, Ma C, Guo W, Kang L (2022) Locust density shapes energy metabolism and oxidative stress resulting in divergence of flight traits. Proc Natl Acad Sci U S A 119:e2115753118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2358_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2164-7-142","volume":"7","author":"RA van den Berg","year":"2006","unstructured":"van den Berg RA, Hoefsloot HCJ, Westerhuis JA, Smilde AK, van der Werf MJ (2006) Centering, scaling, and transformations: Improving the biological information content of metabolomics data. BMC Genomics 7:142","journal-title":"BMC Genomics"},{"key":"2358_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40170-022-00289-6","volume":"10","author":"R An","year":"2022","unstructured":"An R, Yu H, Wang Y, Lu J, Gao Y, Xie X, Zhang J (2022) Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer. Cancer Metab 10:13","journal-title":"Cancer Metab"},{"key":"2358_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11306-011-0330-3","volume":"8","author":"E Szyma\u0144ska","year":"2012","unstructured":"Szyma\u0144ska E, Saccenti E, Smilde AK, Westerhuis JA (2012) Double-check: validation of diagnostic statistics for pls-da models in metabolomics studies. Metabolomics 8:3\u201316","journal-title":"Metabolomics"},{"key":"2358_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/cem.2627","volume":"28","author":"B Galindo\u2010Prieto","year":"2014","unstructured":"Galindo\u2010Prieto B, Eriksson L, Trygg J (2014) Variable influence on projection (VIP) for orthogonal projections to latent structures (OPLS). J Chemom 28:623\u2013632","journal-title":"J Chemom"},{"key":"2358_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-06413-8","volume":"24","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhai Z, Gao T, Kuai X, Li X, Dong Y, Lu C, Zhuo K, Xiang Q, Liu D (2024) Identification of serum metabolic traits of aiwg in first-episode schizophrenia patients. BMC Psychiatry 24:946","journal-title":"BMC Psychiatry"},{"key":"2358_CR35","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41596-022-00710-w","volume":"17","author":"Z Pang","year":"2022","unstructured":"Pang Z, Zhou G, Ewald J, Chang L, Hacariz O, Basu N, Xia J (2022) Using metaboanalyst 5.0 for lc\u2013hrms spectra processing, multi-omics integration and covariate adjustment of global metabolomics data. Nat Protoc 17:1735\u20131761","journal-title":"Nat Protoc"},{"key":"2358_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41398-018-0353-x","volume":"9","author":"B Cao","year":"2019","unstructured":"Cao B, Wang D, Pan Z, Brietzke E, McIntyre RS, Musial N, Mansur RB, Subramanieapillai M, Zeng J, Huang N (2019) Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre-and post-treatment study. Transl Psychiatry 9:19","journal-title":"Transl Psychiatry"},{"key":"2358_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1255501","volume":"14","author":"L Zhao","year":"2023","unstructured":"Zhao L, Liu H, Wang W, Wang Y, Xiu M, Li S (2023) Carnitine metabolites and cognitive improvement in patients with schizophrenia treated with olanzapine: a prospective longitudinal study. Front Pharmacol 14:1255501","journal-title":"Front Pharmacol"},{"key":"2358_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41398-023-02696-9","volume":"13","author":"LA Pan","year":"2023","unstructured":"Pan LA, Naviaux JC, Wang L, Li K, Monk JM, Lingampelly SS, Segreti AM, Bloom K, Vockley J, Tarnopolsky MA (2023) Metabolic features of treatment-refractory major depressive disorder with suicidal ideation. Transl Psychiatry 13:393","journal-title":"Transl Psychiatry"},{"key":"2358_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun YA, Obeid LM (2018) Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol 19:175\u2013191","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2358_CR40","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00109-022-02250-y","volume":"100","author":"F Schumacher","year":"2022","unstructured":"Schumacher F, Carpinteiro A, Edwards MJ, Wilson GC, Keitsch S, Soddemann M, Wilker B, Kleuser B, Becker KA, M\u00fcller CP (2022) Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma. J Mol Med 100:1493\u20131508","journal-title":"J Mol Med"},{"key":"2358_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102185","volume":"298","author":"F Schumacher","year":"2022","unstructured":"Schumacher F, Edwards MJ, M\u00fchle C, Carpinteiro A, Wilson GC, Wilker B, Soddemann M, Keitsch S, Scherbaum N, M\u00fcller BW (2022) Ceramide levels in blood plasma correlate with major depressive disorder severity and its neutralization abrogates depressive behavior in mice. J Biol Chem 298:102185","journal-title":"J Biol Chem"},{"key":"2358_CR42","doi-asserted-by":"crossref","unstructured":"M\u00fchle C, Reichel M, Gulbins E, Kornhuber J (2013) Sphingolipids in psychiatric disorders and pain syndromes. Sphingolipids Disease, pp 431\u2013456","DOI":"10.1007\/978-3-7091-1511-4_22"},{"key":"2358_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1382303","volume":"15","author":"M Lech","year":"2024","unstructured":"Lech M, Ostrowska L, Waszkiewicz N, Ku\u0142ak-Bejda A, Maciejczyk M, Witczak-Sawczuk K, Zalewska A, Da\u0144kowska K, \u017bendzian-Piotrowska M (2024) Oxidative stress parameters in women and men with suicidal thoughts and following a suicide attempt. Front Psychiatry 15:1382303","journal-title":"Front Psychiatry"},{"key":"2358_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/ijnp\/pyac073","volume":"26","author":"FK Giongo","year":"2023","unstructured":"Giongo FK, Gallas-Lopes M, Benvenutti R, Sachett A, Bastos LM, Rosa AR, Herrmann AP (2023) Effects of taurine in mice and zebrafish behavioral assays with translational relevance to schizophrenia. Int J Neuropsychopharmacol 26:125\u2013136","journal-title":"Int J Neuropsychopharmacol"},{"key":"2358_CR45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/15622975.2019.1615639","volume":"21","author":"B Cao","year":"2020","unstructured":"Cao B, Wang D, Pan Z, McIntyre RS, Brietzke E, Subramanieapillai M, Nozari Y, Wang J (2020) Metabolic profiling for water-soluble metabolites in patients with schizophrenia and healthy controls in a Chinese population: a case-control study. World J Biol Psychiatry 21:357\u2013367","journal-title":"World J Biol Psychiatry"},{"key":"2358_CR46","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/metabo12090850","volume":"12","author":"IA Mednova","year":"2022","unstructured":"Mednova IA, Chernonosov AA, Kornetova EG, Semke AV, Bokhan NA, Koval VV, Ivanova SA (2022) Levels of acylcarnitines and branched-chain amino acids in antipsychotic-treated patients with paranoid schizophrenia with metabolic syndrome. Metabolites 12:850","journal-title":"Metabolites"},{"key":"2358_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbaf006","author":"C Lu","year":"2025","unstructured":"Lu C, Dong Y, Qi D, Liu N, Li Y, Chi J, Wang X, Zeng M, Liu F, Li S (2025) Plasma metabolic characteristics and potential biomarker combinations in schizophrenia patients with tardive dyskinesia. Schizophr Bull. https:\/\/doi.org\/10.1093\/schbul\/sbaf006","journal-title":"Schizophr Bull"},{"key":"2358_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bbi.2023.09.017","volume":"115","author":"AJ Murray","year":"2024","unstructured":"Murray AJ, Humpston CS, Wilson M, Rogers JC, Zia Ul Haq Katshu M, Liddle PF, Upthegrove R (2024) Measurement of brain glutathione with magnetic resonance spectroscopy in schizophrenia-spectrum disorders\u2014a systematic review and meta-analysis. Brain Behav Immun 115:3\u201312","journal-title":"Brain Behav Immun"},{"key":"2358_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/wps.20909","volume":"20","author":"ED Klonsky","year":"2021","unstructured":"Klonsky ED, Dixon-Luinenburg T, May AM (2021) The critical distinction between suicidal ideation and suicide attempts. World Psychiatry 20:439\u2013441","journal-title":"World Psychiatry"},{"key":"2358_CR50","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00406-023-01716-5","volume":"274","author":"P Riera-Serra","year":"2024","unstructured":"Riera-Serra P, Navarra-Ventura G, Castro A, Gili M, Salazar-Cedillo A, Ricci-Cabello I, Roldan-Espinola L, Coronado-Simsic V, Garcia-Toro M, Gomez-Juanes R, Roca M (2024) Clinical predictors of suicidal ideation, suicide attempts and suicide death in depressive disorder: a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 274:1543\u20131563","journal-title":"Eur Arch Psychiatry Clin Neurosci"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-026-02358-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-026-02358-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-026-02358-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:49:32Z","timestamp":1789051772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-026-02358-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2358"],"URL":"https:\/\/doi.org\/10.1007\/s00406-026-02358-z","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,30]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Tianjin Anding Hospital (Approval ID: 2022\u201309) and was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No identifying participant data, images, or videos are presented in this manuscript.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}